A detailed history of V Square Quantitative Management LLC transactions in Alkermes Plc. stock. As of the latest transaction made, V Square Quantitative Management LLC holds 1,031 shares of ALKS stock, worth $28,558. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,031
Holding current value
$28,558
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$23.01 - $28.55 $23,723 - $29,435
1,031 New
1,031 $28.9 Million
Q2 2023

Jul 26, 2023

BUY
$28.34 - $33.63 $9,295 - $11,030
328 New
328 $10.3 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.55B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track V Square Quantitative Management LLC Portfolio

Follow V Square Quantitative Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of V Square Quantitative Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on V Square Quantitative Management LLC with notifications on news.